Complementary and Integrative Therapies: Myths, Realities, Challenges for the Future is organized by College of Psychiatric and Neurologic Pharmacists (CPNP).
Activity Dates: 06/01/2017 - 04/25/2020
This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.
ACPE Contact Hours:
Recent data suggests that people with at least one psychiatric or neurologic illness were significantly more likely to seek complementary and alternative medicine (CAM) treatments in the past 12 months, with over 40% reporting turning to these alternative strategies for help. Furthermore, over $34 billion is spent on out of pocket expenditures of alternative medicine in 2007. Patients with anxiety and depressive disorders are particularly noted to use nontraditional treatments. Since depression occurs in up to 10% of patients and anxiety disorders are common, many patients presenting for care are likely to be using complementary and alternative therapies such as exercise, meditation, massage, acupuncture, sleep deprivation, light therapy and nutritional supplements to improve their psychiatric symptoms.
It is critical that behavioral health teams, including pharmacists, are not only aware of the CAM therapies sought out by patients but also understand the evidence base supporting such use. Recent research suggests patient specific biomarkers may help identify individuals responsive to some therapies. This program will review the breadth of complementary and integrative therapies and describe the challenges faced by both manual therapy research and natural products research. Next we will briefly review the current literature investigating natural product studies in mood and anxiety disorders. Finally, we will explore our teams work with St. John’s Wort and N-3 fatty acids to illustrate the state of research in the area of complementary medicine.
• Review the growing use and breadth of complementary therapies for psychiatric disorders.
• Discuss the limitations of research evaluating the effectiveness of complementary therapies.
• Summarize the evidence based literature with regards to efficacy and safety of natural products used to treat mood and anxiety disorders.
• Discern how subject selection may lead to more informative study outcomes.
Additional details will be posted as soon as they are available.